10,000+ stock pitches from top investors available on joinyellowbrick.com
Redmile Group, LLC 13F Holdings
Holdings from the most recent 13F from Redmile Group, LLC
Filed: 2018-08-14 (Q2 2018) | Holdings: 81 | Value: $2.9B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
---|---|---|---|---|---|---|---|
Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
ARRY1 - ARRAY BIOPHARMA INC | New Purchase | 9.11% | $268.1M | ||||
FOLD - AMICUS THERAPEUTICS INC | New Purchase | 5.58% | $164.2M | -58.45% | -24.58% | -27.56% | |
ATRA - ATARA BIOTHERAPEUTICS INC | New Purchase | 5.15% | $151.7M | -99.16% | -6.52% | -65.19% | |
IMGN - IMMUNOGEN INC | New Purchase | 4.07% | $119.8M | -36.49% | -70.04% | ||
XNCR - XENCOR INC | New Purchase | 3.96% | $116.5M | -79.56% | -4.74% | -1.39% | |
RGNX - REGENXBIO INC | New Purchase | 3.81% | $112.0M | -86.93% | -4.84% | -45.80% | |
ALDR - ALDER BIOPHARMACEUTICALS INC | New Purchase | 3.49% | $102.8M | -31.40% | -51.19% | ||
WCG - WELLCARE HEALTH PLANS INC | New Purchase | 2.97% | $87.4M | -14.70% | -6.64% | ||
WVE - WAVE LIFE SCIENCES LTD | New Purchase | 2.92% | $85.9M | -85.05% | -15.80% | -55.93% | |
BOLD - AUDENTES THERAPEUTICS INC | New Purchase | 2.89% | $85.2M | ||||
CLVS - CLOVIS ONCOLOGY INC | New Purchase | 2.72% | $80.0M | ||||
FATE - FATE THERAPEUTICS INC | New Purchase | 2.56% | $75.5M | -89.30% | +11.32% | +55.53% | |
IFRX - INFLARX NV | New Purchase | 2.22% | $65.4M | -97.51% | -12.96% | -92.00% | |
CNC - CENTENE CORP DEL | New Purchase | 2.13% | $62.6M | -22.87% | -4.99% | -33.48% | |
QURE - UNIQURE NV | New Purchase | 2.09% | $61.4M | -58.29% | -14.56% | +54.75% | |
ALXN - ALEXION PHARMACEUTICALS INC | New Purchase | 2.06% | $60.7M | +0.66% | -8.29% | ||
LIVN - LIVANOVA PLC | New Purchase | 2.03% | $59.9M | -63.30% | -0.14% | -37.02% | |
DCPH - DECIPHERA PHARMACEUTICALS IN | New Purchase | 1.97% | $58.1M | -34.10% | +5.25% | ||
ARGX - ARGENX SE | New Purchase | 1.90% | $55.8M | +520.37% | +5.90% | +55.39% | |
ICUI - ICU MED INC | New Purchase | 1.84% | $54.1M | -56.12% | -16.75% | -43.01% | |
LH - LABORATORY CORP AMER HLDGS | New Purchase | 1.76% | $51.8M | +76.33% | -8.56% | -8.94% | |
INSM - INSMED INC | New Purchase | 1.63% | $48.1M | +374.30% | -19.69% | -26.13% | |
SYNH - SYNEOS HEALTH INC | New Purchase | 1.56% | $46.0M | +2.69% | +3.18% | ||
XERS - XERIS PHARMACEUTICALS INC | New Purchase | 1.56% | $45.8M | ||||
BLUE - BLUEBIRD BIO INC | New Purchase | 1.43% | $42.1M | -21.07% | -24.79% | ||
CBAY - CYMABAY THERAPEUTICS INC | New Purchase | 1.35% | $39.7M | -23.26% | -52.43% | ||
MPSY.F - MORPHOSYS AG | New Purchase | 1.31% | $38.5M | -0.14% | +7.32% | ||
ANAB - ANAPTYSBIO INC | New Purchase | 1.25% | $36.9M | -71.04% | -20.15% | -38.10% | |
HSKA - HESKA CORP | New Purchase | 1.25% | $36.8M | +1.45% | -26.64% | ||
UNH - UNITEDHEALTH GROUP INC | New Purchase | 1.19% | $35.1M | +30.65% | +1.47% | -5.38% | |
ELV - ANTHEM INC | New Purchase | 1.18% | $34.8M | +55.46% | +7.96% | +4.99% | |
GLYC - GLYCOMIMETICS INC | New Purchase | 1.11% | $32.7M | -98.94% | -21.77% | -79.50% | |
IRTC - IRHYTHM TECHNOLOGIES INC | New Purchase | 1.11% | $32.6M | +73.44% | -12.88% | -13.47% | |
EHTH - EHEALTH INC | New Purchase | 1.03% | $30.5M | -85.53% | +20.01% | +271.06% | |
OXFD - OXFORD IMMUNOTEC GLOBAL PLC | New Purchase | 0.98% | $28.8M | +4.50% | -3.95% | ||
NITE - NIGHTSTAR THERAPEUTICS PLC | New Purchase | 0.97% | $28.6M | ||||
CTLT - CATALENT INC | New Purchase | 0.94% | $27.7M | -3.05% | +37.21% | ||
ABT - ABBOTT LABS | New Purchase | 0.93% | $27.4M | +134.73% | +11.93% | +34.50% | |
EPZM - EPIZYME INC | New Purchase | 0.93% | $27.4M | -25.27% | +27.66% | ||
SRRK - SCHOLAR ROCK HLDG CORP | New Purchase | 0.93% | $27.3M | +162.81% | +50.36% | -24.75% | |
N/A - ALDER BIOPHARMACEUTICALS INC | New Purchase | 0.89% | $26.1M | ||||
N/A - ARRAY BIOPHARMA INC | New Purchase | 0.87% | $25.5M | ||||
ELGXQ - ENDOLOGIX INC | New Purchase | 0.83% | $24.5M | -59.51% | -75.26% | ||
TFX - TELEFLEX INC | New Purchase | 0.73% | $21.4M | -46.99% | +13.39% | +60.81% | |
ZTS - ZOETIS INC | New Purchase | 0.72% | $21.2M | +79.27% | +0.60% | +36.68% | |
CMRX - CHIMERIX INC | New Purchase | 0.58% | $17.1M | -19.05% | -39.52% | ||
SYRS - SYROS PHARMACEUTICALS INC | New Purchase | 0.57% | $16.7M | -99.98% | -30.70% | -13.60% | |
TCDA - TRICIDA INC | New Purchase | 0.51% | $14.9M | +28.72% | +38.89% | ||
ODTC - ODONATE THERAPEUTICS INC | New Purchase | 0.46% | $13.5M | -13.35% | +75.40% | ||
TDOC - TELADOC INC | New Purchase | 0.46% | $13.4M | -90.11% | -14.90% | -19.63% |